logo
Sign InSign Up

THERMO FISHER SCIENTIFIC INC (TMO)

Sector: Healthcare

Financial Fundamentals

findl.com provides a comprehensive suite of standardized financial statement data and an assortment of calculated metrics sourced directly from SEC filings, and meticulously cleansed and verified, ensuring reliability. To get the complete financial statement history in quarterly and annual resolution for TMO, sign up here.

Income Statement

Revenue

$42.9bn

Gross Profit

$17.1bn

Earning before Tax

$6.3bn

Net Income

$6.0bn

Net Income Common Shareholders

$6.0bn

EPS

15.52

Balance Sheet

Cash

$8.1bn

Debt

$34.9bn

Assets

$98.7bn

Liabilities

$52.0bn

Equity

$46.7bn

Enterprise Value

$234.2bn

Cash Flow Statement

Net Cash from Operations

$8.4bn

Net Cash from Investing

$-5.1bn

Net Cash from Financing

$-3.6bn

Net Cash Flow

$-0.4bn

Free Cash Flow

$7.0bn

Free Cash Flow per Share

$18.17

Metrics

Price to Equity

34.21

Price to Equity (Damodaran)

34.20

Price to Book

4.39

Net Margin

0.14

Return on Equity

0.14

Return on Sales

0.18

Get immediate access to 5-years of reference grade data for TMO for free.

Sign up

Company Profile

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally. The company''s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, clinical next-generation sequencing, bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company''s Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, laboratory chemicals, research and safety market channel, and pharma services and clinical research. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Company Info

Industry

Diagnostics & Research

Employees

Address

168 Third Avenue
Waltham, MA 02451
United States

Phone

781 622 1000

Last Updated

2024-02-19

Available Data

Standardized Financial Statements

EOD Price History

Corporate Actions

Institutional Holdings

Insider Transactions

Sign up for free and get immediate access
logo

Radically accessible financial data

Contact Info

findl.com info@findl.com

Explore findl data

DocumentationSupport

Copyright © findl 2024. All rights reserved.

Terms & Use

Privacy Policy